Carolyn Bertozzi

Person · Female

Carolyn Bertozzi

From
Boston, Stanford
Since
1966–present
Releases
0

About

Carolyn Ruth Bertozzi (born October 10, 1966) is an American chemist and Nobel laureate, known for her wide-ranging work spanning both chemistry and biology. She coined the term "bioorthogonal chemistry" for chemical reactions compatible with living systems, and is a major figure in the field of glycobiology, the study of structural carbohydrates or glycans. Her work focuses on developing tools of analytical chemistry to study glycans and their role in diseases such as cancer, inflammation, and viral infections like COVID-19. At Stanford University, she holds the Anne T. and Robert M. Bass Professorship in the School of Humanities and Sciences. Bertozzi is also an Investigator at the Howard Hughes Medical Institute (HHMI) and is the former director of the Molecular Foundry, a nanoscience research center at Lawrence Berkeley National Laboratory. Since 2024, she has served as a scientific advisory board member of Arc Institute.

Read more

She received the MacArthur "genius" award at age 33. In 2010, she was the first woman to receive the Lemelson–MIT Prize faculty award. She is a member of the National Academy of Sciences (2005), the Institute of Medicine (2011), and the National Academy of Inventors (2013). In 2014, it was announced that Bertozzi would lead ACS Central Science, the American Chemical Society's first peer-reviewed open access journal, which offers all content free to the public. Since 2021 she has been a member of the Accademia dei Lincei.
Bertozzi was awarded the 2022 Nobel Prize in Chemistry, jointly with Morten P. Meldal and Karl Barry Sharpless, "for the development of click chemistry and bioorthogonal chemistry".

From Carolyn Bertozzi on Wikipedia, under CC BY-SA 4.0.

Member of

Links

Identifiers

ISNI
0000000110213091

Data from MusicBrainz, saved 11 Nov 2026. Photo from Wikimedia Commons, covers from the Cover Art Archive and Apple Music.